(Date:11/21/2008).... 21 In a statewide survey, 33 phy...itute for Surgery at Presbyterian Hospital of Dall...ual listing of " Super Doctors ." , , Each ...Key Professional Media, Inc. to survey more than 3...xas to ask, "If you needed medical care, which doc...
(Date:11/21/2008)...E, N.Y., Nov. 21 A prestigious gro...oviders will gather in Williamsburg, VA on March 2...tical, clinical information on cutting-edge therap...innovative research advances that impact patient c... registration information is available at www.bio...
(Date:11/21/2008).... 21 Innerscope Research(TM), a re...izing in Emotional Response Measurement,announce...ll strengthen the,company,s research and developm... , The three appointments, who deliver a co...ill as Chief Financial Officer and Vice President ...
(Date:11/21/2008)...City, Panama - The University of Texas M. D. Ander...orative effort to eradicate breast cancer in Panam...ess and Research of the Americas today at an event...tes, and Vivian Fernndez de Torrijos, the First La...initiative are the U.S. Department of State and Su...
Breaking Medicine News(10 mins):Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2(Date:11/21/2008)... Calif., Nov. 21 Amgen,...n Committee for Medicinal,Products for Human Use ...,marketing authorisation for Nplate(TM) (romiplost...nds Nplate for adult chronic immune (idiopathic),...ents who are refractory to,other treatments (e.g....
(Date:11/20/2008)....J., Nov. 20 New Jersey American W...isory for its customers in the following municipal..., , Middlesex County , , , Du... Piscataway , South Plainfield , , ...und Brook , Bridgewater , Green Broo...
(Date:11/20/2008)...lif., Nov. 20 Bionovo, I...present results from the Phase 1B,clinical trial ...ic breast,cancer, BZL101, at the Society for Inte... in Atlanta, Georgia. The Company,s oral presenta...ill be presented as a part of the Best of the,SIO...
(Date:11/20/2008)...rway, November 20 The Scandinavian...as announced results of studies on its,lead antim...Washington, DC,the studies showed that the novel...cidal effect, significantly better towards killing... than marketed gold standard drugs. In,addition t...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Hampshire Seniors Speak Out Against Medicare Advantage Cuts 23522 1New Hampshire Seniors Speak Out Against Medicare Advantage Cuts 23522 2Lilly to Acquire SGX Pharmaceuticals 6431 1Lilly to Acquire SGX Pharmaceuticals 6431 2Lilly to Acquire SGX Pharmaceuticals 6431 3Lilly to Acquire SGX Pharmaceuticals 6431 4Lilly to Acquire SGX Pharmaceuticals 6431 5Awareness of epidemiologys limitations could reduce impact of false positive cancer results 23521 1Awareness of epidemiologys limitations could reduce impact of false positive cancer results 23521 2Also in the July 8 JNCI 23519 1Also in the July 8 JNCI 23519 2Also in the July 8 JNCI 23519 3Also in the July 8 JNCI 23519 4...IRE)--Jun 18, 2007 - Salix,Pharmaceuticals, Ltd. (...tion and outcome of its Phase III registration tri...00 mg tablet,formulation of balsalazide disodium (...active ingredient in COLAZAL(R),Capsules 750 mg, a... the treatment of mildly to moderately active ulce...
...n achieved at 8 am versus placebo: - 25,/ - 13 mm ...ction dependent on vaccine dose and induced,antian...resented today at the Seventeenth European,Meeting...ich), Switzerland and MILAN, Italy, June 17, 2007 ...y new clinical data,on its hypertension vaccine CY...
Other Medicine Technology:Salix Pharmaceuticals Announces Positive Top Line Results of,Balsalazide Tablets Registration Study 2Salix Pharmaceuticals Announces Positive Top Line Results of,Balsalazide Tablets Registration Study 3Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 2Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 3Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 4Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 5Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 6Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 7Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 8Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 9...ing tasks such as prescription writing, referral l...c. Your office will be ,able to add more appointme...ff., Based on the exam documentation created by th...ommend the appropriate E&M ,code for the visit - t...
... is an Electronic Medical Office (EMO) for the Oph... of your practice. In addition to retrieving and s...ically integrates the patient office flow includin... about patients, and billing information. ChartLog...
Access your patients' electronic medical records over the Internet with CardioChart. As a Web-enabled software application, physicians and clinicians can pull up a patient's cardiology and vascular m
... is a revolutionary Electronic Medical Office (EMO...stomized for the unique needs of your practice. Th...lectronic record system (EMR, EHR, and EPR), and t...fficiency and performance. In addition to retrievi...
Medicine Products: